Open AccessNormal carcinoembryonic antigen indicates benefit from perioperative chemotherapy to gastric carcinoma patients
Author(s) -
Shi Chen
Publication year - 2012
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v18.i29.3910
Subject(s) - medicine , carcinoembryonic antigen , perioperative , oxaliplatin , chemotherapy , gastroenterology , cancer , gastrectomy , oncology , colorectal cancer , surgery
To evaluate pretreatment serum carcinoembryonic antigen (CEA) as a predictor of survival for patients with locally advanced gastric cancer receiving perioperative chemotherapy.